# RVRC (REVIUM Rx.) - SEC EDGAR Financial Statements

> REVIUM Rx. reported $7.11M in total assets and a net loss of $13.45M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RVRC
- Markdown: https://convexityos.com/fundamentals/RVRC.md
- SEC CIK: 0001839140
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001839140&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$13.45M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.22 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | $842K | Total debt: $128K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Income Tax Expense | $358K |
| **Net Income** | -$13.45M |
| Basic EPS | -$0.22 |
| **Diluted EPS** | -$0.22 |
| Basic Shares Outstanding | 60.7M |
| Diluted Shares Outstanding | 60.7M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- |
| Research & Development | $443K | $473K | $391K | $218K |
| **Operating Income** | -$732K | -$739K | -$938K | -$737K |
| **EBITDA** | -$732K | -$737K | -- | -- |
| **Net Income** | -$748K | -$725K | -$1.04M | -$634K |
| Basic EPS | $0.01 | $0.01 | $0.02 | $0.01 |
| **Diluted EPS** | $0.01 | $0.01 | $0.02 | $0.01 |
| Basic Shares Outstanding | 60.7M | 60.7M | 60.7M | 60.7M |
| Diluted Shares Outstanding | 60.7M | 60.7M | 60.7M | 60.7M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $1.68M | $3.27M |
| **Cash & Short-Term Investments** | $1.68M | $3.27M |
| Other Current Assets | $375K | $238K |
| **Total Current Assets** | $3.10M | $5.52M |
| Property, Plant & Equipment, Net | $10K | $9.0K |
| Goodwill | $2.58M | $11.41M |
| Intangible Assets | $2.50M | $3.34M |
| **Total Non-Current Assets** | $5.21M | $14.77M |
| **Total Assets** | $8.30M | $20.28M |
| Accounts Payable | $163K | $142K |
| **Total Current Liabilities** | $799K | $576K |
| **Total Non-Current Liabilities** | $621K | $0 |
| **Total Liabilities** | $1.42M | $576K |
| **Total Debt (incl. Leases)** | $106K | -- |
| Common Stock | $61K | $61K |
| Retained Earnings | -$24.96M | -$11.51M |
| **Total Stockholders' Equity** | $6.88M | -- |
| Total Equity | $6.88M | $19.71M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Dec 2024 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $842K | $920K | $1.68M | $3.27M |
| **Cash & Short-Term Investments** | $842K | $920K | $1.68M | $3.27M |
| Other Current Assets | $341K | $334K | $375K | $238K |
| **Total Current Assets** | $1.86M | $2.48M | $3.10M | $5.52M |
| Property, Plant & Equipment, Net | $9.0K | $9.0K | $10K | $9.0K |
| Goodwill | $2.58M | $2.58M | $2.58M | $11.41M |
| Intangible Assets | $2.50M | $2.50M | $2.50M | $3.34M |
| **Total Non-Current Assets** | $5.25M | $5.27M | $5.21M | $14.77M |
| **Total Assets** | $7.11M | $7.75M | $8.30M | $20.28M |
| Accounts Payable | $620K | $231K | $163K | $142K |
| **Total Current Liabilities** | $971K | $1.53M | $799K | $576K |
| **Total Non-Current Liabilities** | $619K | $67K | $621K | $0 |
| **Total Liabilities** | $1.59M | $1.60M | $1.42M | $576K |
| **Total Debt (incl. Leases)** | $128K | $151K | $106K | -- |
| Common Stock | $61K | $61K | $61K | $61K |
| Retained Earnings | -$26.43M | -$25.69M | -$24.96M | -$11.51M |
| **Total Stockholders' Equity** | $5.52M | $6.16M | $6.88M | -- |
| Total Equity | $5.52M | $6.16M | $6.88M | $19.71M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Net Income | -$13.45M |
| Stock-Based Compensation | $624K |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- |
| Net Income | -$748K | -$725K | -$1.04M | -$634K |
| Depreciation & Amortization | $0 | $2.0K | -- | -- |
| Stock-Based Compensation | $111K | -- | $154K | $340K |
| Change in Payables | $389K | $68K | $52K | -$5.0K |
| **Operating Cash Flow** | -$626K | -$541K | -$759K | -$357K |
| Purchases of Investments | -$1.0K | -$18K | -- | -- |
| **Investing Cash Flow** | $548K | -$217K | $496K | $1.00M |
| **Net Change in Cash** | -$78K | -$758K | -$263K | $643K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Return on Equity (ROE) | -195.5% |
| Return on Assets (ROA) | -162.0% |
| Current Ratio | 3.87x |
| Quick Ratio | 2.10x |
| Debt to Equity | 0.02x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- |
| Current Ratio | 1.91x | 1.62x | -- | -- |
| Quick Ratio | 0.87x | 0.60x | -- | -- |
| Debt to Equity | 0.02x | 0.02x | -- | -- |
| EPS Growth (YoY) | -50.0% | 0.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
